Decline in serum cholinesterase activities predicts 2-year major adverse cardiac events.
Arbel Y, Shenhar-Tsarfaty S, Waiskopf N, Finkelstein A, Halkin A, Revivo M, Berliner S, Herz I, Shapira I, Keren G, Soreq H, Banai S.
Arbel Y, et al. Among authors: revivo m.
Mol Med. 2014 Feb 12;20(1):38-45. doi: 10.2119/molmed.2013.00139.
Mol Med. 2014.
PMID: 24395570
Free PMC article.